Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Shift to value-based medicine will boost mHealth uptake

Advances in devices and network coverage will also both contribute, say analysts

mobile health mHealth pharma

The healthcare sector’s shift towards value-based medicine will drive the continued uptake and mainstreaming of mobile health (mHealth) services and solutions.

The use of mHealth will also be led by advances in mobile devices and network coverage, combined with falling prices for wireless technologies, according to GBI Research.

Managing analyst Rodrigo Gutierrez Gamboa said: “These technologies have huge potential to bridge the gap within existing healthcare systems, offering an alternative form of healthcare communication and treatment at a distance.

“As the uptake of mHealth technologies increases, support from healthcare professionals, reimbursement entities and government agencies will also increase as the body of literature documenting the wide range of mHealth’s benefits continues to grow.”

Globally the continued acceleration of mobile penetration will, he added, make mHealth services and solutions possible “even in the most remote areas”.

Key drivers for mHealth uptake outlined in GBI Research’s new Mobile Health (mHealth) Technologies: Global Market Prospects report start with the need for more cost-effective means to deliver healthcare.

That’s followed by followed by an increasing need to demonstrate the value and effectiveness of treatments and to win more support for mHealth solutions from healthcare professionals and reimbursement bodies.

Gutierrez Gamboa added: “These three factors are directly linked to the significant challenge governments in all key markets are facing regarding the rising cost of providing healthcare.

“Insurance companies and national healthcare agencies are increasingly demanding more evidence for the cost-effectiveness of treatments. mHealth technologies can significantly lower the cost of healthcare, starting with the ability to provide medical consultations at a distance.”

23rd June 2017

From: Healthcare

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

translational pharmacology medicine dose
The gold standard of scientific evidence
Will randomised controlled trials become a thing of the past?...
What does programmatic advertising mean for your pharma marketing strategy?
Senior Associate Consultant Jiayi Chen explains the benefits and pitfalls of programmatic advertising and reveals how it can impact return on investment in your marketing campaigns....
Discover who are the most engaging Pharma companies on Twitter
With engagement such a key performance metric we first created a weighted formula, incorporating likes, retweets and replies, which produced an engagement score for each account....

Infographics